AMXT-1501

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameAMXT-1501
Drug Alias NameAMXT-1501AMXT 1501 dicaprateAMX-513AMX513 dicaprate
ClassificationSmall molecules
Mechanisms of ActionN-myc proto-oncogene protein inhibitors
TargetsN-myc proto-oncogene protein
Therapy Area/IndicationsSolid tumoursDiffuse midline gliomaDrug-Related Side Effects and Adverse Reactions +[25
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAminex Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBrain NeoplasmsBreast NeoplasmsTeratoma +[11
Inactive IndicationsSolid tumoursDiffuse midline gliomaDrug-Related Side Effects and Adverse Reactions +[14

Other Information

ATC CodeN/A
Related LinksN/A